Publications

Differential and Combinatorial Mechanism of Action of Golimumab and Guselkumab in Ulcerative Colitis Induction Therapy: IL-23 Blockade Drives Restoration of Normal Epithelium and Mucosal Healing

Publié en January 2023 ARTHRITIS & RHEUMATOLOGY
January 2023

GUSELKUMAB INDUCTION RESTORES INTESTINAL IMMUNE HOMEOSTASIS AND PROMOTES EPITHELIAL REPAIR IN MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

ARTHRITIS & RHEUMATOLOGY
Previous publication
January 2023

Blocking CXCR4 improves pulmonary and cardiac outcomes in a mouse model of early COPD

ARTHRITIS & RHEUMATOLOGY
Next publication

Authors